Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-04-16 Purchase |
2021-04-20 9:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Lux Ventures IV L.P. Lux Co-Invest Opportunities L.P. Lux Co-Invest Partners LLC Lux Venture Partners IV LLC 10% Owner |
100,000 | $18 | $1,800,000 | 17,287,095 (Indirect) |
View |
| 2021-04-16 Purchase |
2021-04-20 5:06 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
2,777,777 | $18 | $49,999,986 | 8,740,917 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2021-11-03 4:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | MIC Capital Partners (Public) Parallel Cayman LP MIC Capital Management UK LLP MIC CAPITAL PARTNERS (PUBLIC) (US) IM LLC 10% Owner |
0 | $0 | 1,388,889 (Indirect) |
View |
| 2021-10-01 Option Award |
2021-10-05 8:35 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
858 | $0 | 7,629 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-05 8:33 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
629 | $0 | 133,822 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-05 8:31 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
572 | $0 | 7,169 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-05 8:29 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
295 | $0 | 13,620,005 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-05 8:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
457 | $0 | 7,689,091 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-05 8:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
543 | $0 | 3,819,311 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
347 | $0 | 6,597 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
278 | $0 | 7,688,634 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
521 | $0 | 6,771 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
330 | $0 | 3,818,768 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
382 | $0 | 133,193 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 5:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
295 | $0 | 13,619,519 (Direct) |
View |
| 2021-06-02 Exercise |
2021-06-04 4:00 pm |
N/A 2030-03-20 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
45,045 | $0 | 750,000 (Direct) |
View |
| 2021-06-02 Exercise |
2021-06-04 4:00 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
45,045 | $2.22 | 750,000 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 8:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
18,000 | $0 | 786,000 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 8:12 pm |
N/A 2030-03-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
1,464,000 | $0 | 786,000 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 8:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
528,762 | $0 | 3,906,599 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 8:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
4,789,703 | $0 | 3,906,599 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 8:06 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
3,818,438 | $0 | 9,611,044 (Indirect) |
View |
| 2021-04-20 Conversion |
2021-04-22 8:06 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
166,322 | $0 | 9,611,044 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 8:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
52,500 | $0 | 1,020,000 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 8:03 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
1,725,000 | $0 | 1,020,000 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:59 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
1,081,250 | $0 | 543,750 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 7:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
9,467,883 | $0 | 29,903,649 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
3,110,766 | $0 | 29,903,649 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:53 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
1,500,000 | $0 | 750,000 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
9,559,460 | $0 | 7,700,856 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 7:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Data Collective IV L.P. Data Collective IV GP LLC DCVC V GP LLC DCVC V L.P. DCVC Opportunity Fund II GP LLC DCVC Opportunity Fund II L.P. Ocko Matthew 10% Owner |
13,619,224 | $0 | 30,965,411 (Indirect) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Data Collective IV L.P. Data Collective IV GP LLC DCVC V GP LLC DCVC V L.P. DCVC Opportunity Fund II GP LLC DCVC Opportunity Fund II L.P. Ocko Matthew 10% Owner |
23,511,485 | $0 | 30,965,411 (Indirect) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:43 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
1,081,250 | $0 | 543,750 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 7:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
126,561 | $0 | 803,121 (Direct) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:38 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
840,626 | $0 | 803,121 (Direct) |
View |
| 2021-04-20 Other |
2021-04-22 7:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
13,619,224 | $0 | 30,965,411 (Indirect) |
View |
| 2021-04-20 Conversion |
2021-04-22 7:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
23,511,485 | $0 | 30,965,411 (Indirect) |
View |
| 2021-04-20 Conversion |
2021-04-20 9:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Lux Ventures IV L.P. Lux Co-Invest Opportunities L.P. Lux Co-Invest Partners LLC Lux Venture Partners IV LLC 10% Owner |
51,536,283 | $0 | 17,287,095 (Indirect) |
View |
Ownership |
2021-04-20 5:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | MIC CAPITAL PARTNERS (PUBLIC) (US) IM LLC 10% Owner |
0 | $0 | 1,388,889 (Indirect) |
View |
| 2021-04-20 Conversion |
2021-04-20 5:06 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
15,333,484 | $0 | 8,740,917 (Indirect) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:28 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
41,667 | $0 | 3,846,216 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:27 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
18,750 | $0 | 543,750 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:25 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
18,750 | $0 | 543,750 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:23 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
18,750 | $0 | 543,749 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 7:21 pm |
N/A 2031-04-14 |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
18,750 | $0 | 7,700,856 (Direct) |
View |
Ownership |
2021-04-15 3:49 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
0 | $0 | 13,026,009 (Indirect) |
View |
Ownership |
2021-04-15 3:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Data Collective IV L.P. Data Collective IV GP LLC DCVC V GP LLC DCVC V L.P. DCVC Opportunity Fund II GP LLC DCVC Opportunity Fund II L.P. Ocko Matthew 10% Owner |
0 | $0 | 13,619,224 (Indirect) |
View |
Ownership |
2021-04-15 3:43 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Bogue Zachary Director 10% Owner |
0 | $0 | 13,619,224 (Indirect) |
View |
Ownership |
2021-04-15 2:18 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Lux Ventures IV L.P. Lux Co-Invest Opportunities L.P. Lux Co-Invest Partners LLC Lux Venture Partners IV LLC 10% Owner |
0 | $0 | 17,187,095 (Direct) |
View |
Ownership |
2021-04-15 09:03 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Virani Shafique Chief Corp. Dev. Officer |
0 | $0 | 750,000 (Direct) |
View |